Two-Year Study of the Safety and Efficacy of the Second-Generation Tissue Engineered Vascular Grafts
Two-Year Study of the Safety and Efficacy of the Second-Generation Tissue Engineered Vascular Grafts
Recruiting · NCT04467671 · Registry updated 2025-06-27Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Two-Year Study of the Safety and Efficacy of the Second-Generation Tissue Engineered Vascular Grafts | Cardiovascular Abnormalities, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, cardiovascular disorder, congenital heart disease, double outlet right ventricle, heart disorder, heart valve disorder, hypoplastic left heart syndrome, mitral atresia disorder, tricuspid atresia, univentricular heart | Recruiting | Phase 2 | 2025-06-27 | NCT04467671 |
4 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Gunze Limited | 1 |
| National Heart, Lung, and Blood Institute (NHLBI) | 791 |
| National Institutes of Health (NIH) | 667 |
| Nationwide Children's Hospital | 97 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Nationwide Children's Hospital | Columbus | United States | 309 |